quinoxalines has been researched along with Allergic Encephalomyelitis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnoux, I; Barger, Z; Bittner, S; Ellwardt, E; Jubal, ER; Kuhlmann, T; Luchtman, D; Lutz, B; Mandal, S; Mittmann, T; Novkovic, T; Pramanik, G; Ruiz de Azua, I; Schmalz, M; Stroh, A; Vogelaar, CF; Vogt, J; Zipp, F | 1 |
| Che, T; Kalinin, DV; Loser, K; Mykicki, N; Schepmann, D; Ständer, S; Tangherlini, G; Wünsch, B | 1 |
| Bankala, R; Doss, HM; Kapavarapu, RK; Kulkarni, P; Kumar, JS; Mathew, JE; Medishetti, R; Mudgal, J; Pal, M; Parsa, KVL; Ramarao, EVVS; Rasool, M; Shenoy, GG; Sunke, R; Thirupataiah, B | 1 |
| Elkabes, S; Giraud, SN; Heary, RF; Jain, MR; Kurnellas, MP; Li, H; Nicot, AB; Ratnayake, A | 1 |
| Comerford, I; Kara, E; Litchfield, W; McColl, SR | 1 |
| Groom, AJ; Smith, T; Turski, L | 1 |
| Kanwar, JR; Kanwar, RK; Krissansen, GW | 1 |
| Groom, A; Smith, T; Turski, L; Zhu, B | 1 |
| Pitt, D; Raine, CS; Werner, P | 2 |
| Hanada, T; Hashimoto, T; Nishizawa, Y; Ohgoh, M; Smith, T; Ueno, M; Watanabe, M; Yamanishi, Y | 1 |
11 other study(ies) available for quinoxalines and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cells, Cultured; Cerebral Cortex; Cuprizone; Disease Models, Animal; Egtazic Acid; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Freund's Adjuvant; Hyperkinesis; Membrane Potentials; Mice; Mice, Transgenic; Microglia; Myelin Proteolipid Protein; Peptide Fragments; Proto-Oncogene Proteins c-fos; Quinoxalines; Recovery of Function; Sodium Channel Blockers; Tetrodotoxin | 2018 |
Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation.
Topics: Animals; Antineoplastic Agents; Binding Sites; Encephalomyelitis, Autoimmune, Experimental; HEK293 Cells; Humans; Interferon-gamma; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Docking Simulation; Protein Structure, Tertiary; Quinoxalines; Receptors, Opioid, kappa; Signal Transduction; Structure-Activity Relationship; Th1 Cells | 2019 |
InCl
Topics: Animals; Arthritis; Cyclic Nucleotide Phosphodiesterases, Type 4; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Indium; Indoles; Molecular Structure; Multiple Sclerosis; Oligodendrocyte-Myelin Glycoprotein; Phosphodiesterase 4 Inhibitors; Quinoxalines; Rats; Structure-Activity Relationship; Zebrafish; Zebrafish Proteins | 2019 |
Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons.
Topics: Animals; Calcium-Binding Proteins; Calpain; Cell Death; Cell Survival; Cells, Cultured; Cysteine Proteinase Inhibitors; Embryo, Mammalian; Encephalomyelitis, Autoimmune, Experimental; Gene Expression; Kainic Acid; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Phosphoproteins; Plasma Membrane Calcium-Transporting ATPases; Proteome; Proteomics; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, AMPA; Receptors, Kainic Acid; RNA, Small Interfering; Spinal Cord | 2010 |
PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.
Topics: Administration, Oral; Animals; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Movement; Cell Survival; Central Nervous System; Class Ib Phosphatidylinositol 3-Kinase; Cross-Priming; Cytokines; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Deletion; Humans; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; Quinoxalines; Signal Transduction; Th1 Cells; Th17 Cells; Thiazolidinediones | 2012 |
Multiple sclerosis and glutamate.
Topics: Animals; Brain Stem; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mice; Mice, Inbred Strains; Multiple Sclerosis; Nootropic Agents; Pyrrolidinones; Quinoxalines; Rats; Receptors, AMPA; Spinal Cord | 2003 |
Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Axons; Cell Adhesion Molecules; Cytokines; Disease Progression; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Immunoglobulins; Integrins; Mice; Mice, Inbred C57BL; Mucoproteins; Multiple Sclerosis; Neuroprotective Agents; Oligodendroglia; Quinoxalines; Receptors, Glutamate; Treatment Outcome; Weight Gain | 2004 |
Autoimmune encephalomyelitis ameliorated by AMPA antagonists.
Topics: Animals; Brain Stem; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Guinea Pigs; Motor Neurons; Multiple Sclerosis; Muscle Tonus; Myelin Basic Protein; Neurons; Organophosphonates; Quinoxalines; Rats; Rats, Inbred Lew; Receptors, AMPA; Receptors, Kainic Acid; Recurrence; Spinal Cord; T-Lymphocytes | 2000 |
Glutamate excitotoxicity in a model of multiple sclerosis.
Topics: Animals; Axons; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred Strains; Multiple Sclerosis; Quinoxalines; Receptors, AMPA; Receptors, Kainic Acid; T-Lymphocytes | 2000 |
Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
Topics: Animals; Axons; Cell Death; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Glutaminase; Humans; Mice; Mice, Inbred Strains; Multiple Sclerosis; Myelitis; Neuroprotective Agents; Neurotoxins; Oligodendroglia; Quinoxalines; Receptors, AMPA | 2000 |
Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis.
Topics: Amino Acid Transport System X-AG; Animals; Carrier Proteins; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Gene Expression; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Quinoxalines; Rats; Rats, Inbred Lew; Receptors, AMPA; RNA, Messenger; Spinal Cord; Symporters; Tritium | 2002 |